← All companies
RYTM
Rhythm Pharmaceuticals, Inc.
$102.78
-2.96 -2.80%
Key statistics
from XBRL data in SEC filingsMarket cap
$7.04B
Revenue (TTM)
$217M
Net income (TTM)
-$6.34M
EPS (TTM)
$-3.13
P/E ratio
—
Dividend yield
—
Free cash flow
-$117M
Cash
$62.1M
Total assets
$442M
Gross margin
—
52-week range
$74.50 – $122.20
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 25, 2026
8-K
Regulation FD disclosure; Other events
Jun 15, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Results of operations (earnings release)
May 5, 2026
8-K
Director or officer change; Regulation FD disclosure
Apr 3, 2026
8-K
Regulation FD disclosure; Other events
Mar 26, 2026
8-K
Regulation FD disclosure; Other events
Mar 20, 2026
8-K
Regulation FD disclosure; Other events
Mar 16, 2026
8-K
Regulation FD disclosure; Other events
Mar 2, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Jan 9, 2026
8-K
Director or officer change
Dec 19, 2025
8-K
Regulation FD disclosure; Other events
Dec 11, 2025
8-K
Regulation FD disclosure; Other events
Nov 7, 2025
10-Q
Quarter ended 2025-09-30
Nov 4, 2025
8-K
Results of operations (earnings release)
Nov 4, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release)
Aug 5, 2025
8-K
Other events
Jul 11, 2025
8-K
Regulation FD disclosure; Other events
Jul 9, 2025
8-K
Amended charter or bylaws; Shareholder vote results
Jun 26, 2025
10-Q
Quarter ended 2025-03-31
May 7, 2025
8-K
Results of operations (earnings release)
May 7, 2025
8-K
Regulation FD disclosure; Other events
Apr 7, 2025
8-K
Terminated a material agreement; Regulation FD disclosure
Mar 20, 2025
8-K
Other events
Feb 28, 2025
10-K
Fiscal year ended 2024-12-31
Feb 28, 2025
8-K
Results of operations (earnings release)
Feb 26, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Jan 10, 2025
10-Q
Quarter ended 2024-09-30
Nov 6, 2024
8-K
Results of operations (earnings release)
Nov 5, 2024
8-K
Shareholder vote results
Sep 19, 2024
10-Q/A
Quarter ended 2024-06-30
Aug 14, 2024
10-Q
Quarter ended 2024-06-30
Aug 6, 2024
8-K
Results of operations (earnings release)
Aug 6, 2024
8-K
Other events
Jul 10, 2024
8-K
Other events
Jun 17, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release)
May 7, 2024